Vertex mainly researches and produces various small molecule drugs for the treatment of terminal diseases. Its famous products include Casgevy, the world’s first gene editing therapy, Suzetrigine, a new three-effect cystic fibrosis therapy, Ivacaftor, and anti-hepatitis C drugs. Telaprevir, etc.
Tag: VRTX
How does CRISPR, the gene editing inventor, make money?
CRISPR is a biotech company headquartered in Switzerland. Founded in 2013 by Emmanuelle Charpentier, Shaun Foy and Rodger Novak. It is the first biotechnology company to use CRISPR gene editing and received world first approved.
World’s first gene editing therapy Casgevy finally approved
Casgevy, the world’s first gene edit therapy, is an important milestone in the biotech industry and may change the world’s biotech pharmaceutical landscape in the future.